Kamal et al. studied MSH2 protein expression using IHC in 673 tumor tissue paraffin-embedded samples from patients with resected NSCLC who received adjuvant platinum-based chemotherapy, reporting that MSH2 protein expression was a predictive factor [16]. Here, MSH2 is linked to non-small cell lung carcinoma.